Medical Director Bio John Ervin, MD

Professional Biography
Dr. John E. Ervin earned his undergraduate degree at the University of Notre Dame and received his medical degree from the University of Kansas School of Medicine in 1976.

There he completed a Residency in Internal Medicine and a Fellowship in Allergy, Immunology, and Rheumatology. He is board-certified in both Internal Medicine and Rheumatology. In addition, Dr. Ervin has been on the teaching staff at both the University of Kansas Medical Center and the University of Missouri -- Kansas City.

John E. Ervin, M.D., F.A.C.P., F.A.C.R. founded The Center for Pharmaceutical Research in 1986, and serves as the President / General Manager, Medical Director, and Principal Investigator. He was the first president and co-founder of The Society of Principal Investigators and is a founding member of The Alliance for Multispecialty Research. He has conducted over 730 phase I through IV clinical trials.

Dr. Ervin's professional credentials include:

  • Patients' Choice Award recipient, 2008, 2009, 2010, 2011 (Top 5% of physicians)
  • “America's Top Physicians 2010" - Consumer Research Council of America
  • Premier Physician 2009 voted by nursing staff of St. Joseph Medical Center
  • Outstanding Resident on the Medical Services, University of Kansas School of Medicine 1975-1976, selected by attending staff
  • Kansas City Magazine “BEST DOCTORS” as chosen by peers, 2003, 2007 and 2008
  • Awarded Kansas City’s Rheumatology “Super Doctor” chosen by peers, 2007 and 2008
  • Assistant Clinical Professor of Medicine and Preceptor, University of Kansas School of Medicine, Kansas City, Kansas, 1985-2009
  • Assistant Clinical Professor of Medicine and Preceptor, University of Missouri at Kansas City School of Medicine, 1977-2009
  • American Academy of Pharmaceutical Physicians (wrote 1st ever editorial for quarterly publication)
  • Featured speaker for D.I.A. Webinar conference on matters pertaining to clinical research
  • Fellow American College of Physicians (FACP)
  • Founding Fellow, American College of Rheumatology (FACR)
  • Founder, President, CEO, Medical Director, Principal Investigator, The Center for Pharmaceutical Research, 1986-Present
  • President, Medical Director, Arthritis & Osteoporosis Associates, 2005-2009
  • President, Internal Medicine and Arthritis Associates, 1997-2005
  • Medical Director, Carondelet Internal Medical Physicians, 1992-1997
  • Medical Director, Carondelet Internal Medical Physicians, 1992-1997
  • Arthritis Care Center of St. Joseph Health Center, Medical Director, 1992-1996
  • Carondelet Health Corporation, Board of Directors, 1992-1997
  • Carondelet Manor Nursing Home, Medical Director, 1983-1995
  • Saint Joseph Health Center
    • Board of Directors, 1989-1992
    • Chairman, Department of Medicine, 1989-1991
    • Chairman of Medical Education, 1989-1991
    • Vice Chairman, Department of Medicine, 1983-1984
  • Arthritis Foundation, Greater Kansas City – Western Missouri Chapter
    • Member, 1979–Present
    • Board of Directors, 1990-1995
    • Chairman of the Board, 1986-1988
    • President, 1983-1986
    • Vice President, 1982-1983
  • Board of Directors, Western Central Osteoporosis Board, 1999–2007
  • Society of Pharmaceutical Investigators
    • President, 2005-2006
    • Board of Directors, 2002-2006
  • Member of the Osteoarthritis Research Society
  • Member of the Association of Clinical Pharmacology
  • Charter Member of The Alliance for Better Bone Health
  • Member of the American Academy of Pharmaceutical Physicians and Investigators (AAPPI)
  • Planning Committee Member of The AAPP, 2002 - 2003
  • Founding Member and Past President, The Alliance for Multispecialty Research

The Alliance for Multispecialty Research, LLC (AMR) performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development new drugs, devices, and vaccines. AMR includes 15 locations and 2 affiliated member centers across the continental United States, 126 investigators, over 7,749 previous clinical trials, and access to databases of over 657,344 patients. As one company, AMR now offers improved efficiencies with the same exceptional quality and industry professionals you trust.
Please visit for more information.